Cargando…

Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8(+) T Cells for Cancer Immunotherapy

BACKGROUND: Prostate cancer is the most common cancer among elderly men in the US, and immunotherapy has been shown to be a promising strategy to treat patients with metastatic castration-resistant prostate cancer. Efforts to identify novel prostate specific tumor antigens will facilitate the develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsueda, Satoko, Wang, Mingjun, Weng, Jinsheng, Li, Ying, Yin, Bingnan, Zou, Jia, Li, Qingtian, Zhao, Wei, Peng, Weiyi, Legras, Xavier, Loo, Christopher, Wang, Rong-Fu, Wang, Helen Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447865/ https://www.ncbi.nlm.nih.gov/pubmed/23029225 http://dx.doi.org/10.1371/journal.pone.0045756

Ejemplares similares

Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8(+) T Cells: Implication for Cancer Immunotherapy
por: Wang, Mingjun, et al.
Publicado: (2013)

Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4(+) Th1 Cells
por: Kiniwa, Yukiko, et al.
Publicado: (2015)

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time
por: Noguchi, Masanori, et al.
Publicado: (2013)

EGFR T790M mutation as a novel target for immunotherapy against EGFR-TKI-resistant non-small cell lung cancer
por: Sasada, Tetsuro, et al.
Publicado: (2013)

Human tumor antigens recognized by T lymphocytes
Publicado: (1996)

Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
por: Kiessling, Andrea, et al.
Publicado: (2012)

Detection and Cloning of a Protein Recognized by Anti‐human Prostate‐specific Antigen (PSA) Antibody in the Rat Ventral Prostate
por: Onozawa, Mizuki, et al.
Publicado: (2001)

Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
por: Nobuoka, Daisuke, et al.
Publicado: (2012)

Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy
por: Liu, Xin, et al.
Publicado: (2022)

Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA
por: Raoofi Mohseni, Sahar, et al.
Publicado: (2019)

Approaches for Recognizing Disease Genes Based on Network
por: Zou, Quan, et al.
Publicado: (2014)

Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)

Hematopoietic lineage-converted T cells carrying tumor-associated antigen-recognizing TCRs effectively kill tumor cells
por: Hu, Fangxiao, et al.
Publicado: (2020)

Immunotherapy for Prostate Cancer: Lessons from Responses to Tumor-Associated Antigens
por: Westdorp, Harm, et al.
Publicado: (2014)

TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells
Publicado: (1994)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
por: Wang, Rong-Fu, et al.
Publicado: (1996)

A Novel Strategy to Screen Bacillus Calmette-Guérin Protein Antigen Recognized by γδ TCR
por: Xi, XueYan, et al.
Publicado: (2011)

TCR-like antibodies in cancer immunotherapy
por: He, Qinghua, et al.
Publicado: (2019)

Mutant p53 as an Antigen in Cancer Immunotherapy
por: Sobhani, Navid, et al.
Publicado: (2020)

Pretraining to Recognize PICO Elements from Randomized Controlled Trial Literature
por: Kang, Tian, et al.
Publicado: (2019)

Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
por: Yutani, Shigeru, et al.
Publicado: (2013)

Critical role of histone demethylase Jmjd3 in the regulation of CD4(+) T cell differentiation
por: Li, Qingtian, et al.
Publicado: (2014)

Identification of Theileria lestoquardi Antigens Recognized by CD8(+) T Cells
por: Goh, Shan, et al.
Publicado: (2016)

Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
por: Wang, Shixiang, et al.
Publicado: (2019)

Effector CD4(+) T cells recognize intravascular antigen presented by patrolling monocytes
por: Westhorpe, Clare L. V., et al.
Publicado: (2018)

Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte‐specific protein tyrosine kinase
por: Matsueda, Satoko, et al.
Publicado: (2018)

Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue
por: Arima, Yoshimi, et al.
Publicado: (2023)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017)

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review
por: Martin, Felicity C., et al.
Publicado: (2023)

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Han, Chungyong, et al.
Publicado: (2018)

Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4(+)T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis
por: Wang, Helen Y., et al.
Publicado: (2002)

Characterization of antigens recognized by natural killer cells in cell-culture supernatants.
por: Zaunders, J., et al.
Publicado: (1981)

T cells recognize minor histocompatibility antigens on H-2 allogeneic cells
Publicado: (1979)

Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera
Publicado: (1984)

Cytotoxic T cells recognize male antigen and H-2 as distinct entities
Publicado: (1978)

Molecular cloning of candidate antigens recognized by anti-endothelial cell antibodies
por: Revelen, R, et al.
Publicado: (2002)

Integration of quantitative diffusion kurtosis imaging and prostate specific antigen in differential diagnostic of prostate cancer
por: Yao, Weigen, et al.
Publicado: (2021)

Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
por: Sha, Huan-huan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tppmf12l8lr5upn1h94n8fse9j